Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.
2008
Introduction
Finding new immunohistochemical markers that are specific to hereditary breast cancer could help us to select candidates for BRCA1/BRCA2 mutation testing and to understand the biological pathways of tumour development.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
24
Citations
NaN
KQI